Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Assessing cognitive impairment in young adults after ischemic stroke

Official title: Trajectories of Neurocognitive Impairment After Ischemic Stroke in Young Subjects

Run by Centre Hospitalier Universitaire de Nice · NCT06262529 · Data updated 2026-11-12

This study is testing how an ischemic stroke affects thinking and memory in young adults aged 18-45 over time.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment16 (estimated)
SponsorCentre Hospitalier Universitaire de Nice
Academic / other
Locations2 sites (Cannes and 1 other locations)
StatusRecruiting
StartedFebruary 8, 2024
Main results expectedMay 9, 2025
Study endsMay 9, 2027
Registry record updatedMarch 20, 2025
Trial IDNCT06262529 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are young adults aged 18 to 45 who have been diagnosed with an ischemic stroke.

Probably not a fit

Patients with pre-existing cognitive impairments or severe functional dependence prior to the stroke may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on young adults aged 18-45 who have experienced an ischemic stroke, a condition affecting a significant number of individuals in France. It aims to evaluate the prevalence and evolution of cognitive impairment in these patients over time through comprehensive neuropsychological assessments and functional evaluations. By conducting repeated assessments, the study seeks to provide valuable longitudinal data on neurocognitive trajectories in this demographic, which is currently lacking in the literature.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of cognitive impairments in young stroke survivors.

How similar studies have gone: While studies on post-stroke cognition exist, this specific focus on young adults with ischemic stroke and their neurocognitive trajectories is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 18 to 45 years.
* Pathology: ischemic stroke diagnosed with brain MRI as per standard clinical practice, with or without occlusion of proximal artery, anterior or posterior circulation.
* Ability to understand and complete study tests and questionnaires: fluent French speaker and reader.
* All patients must be affiliated to a social security scheme.
* Signature of informed consent form.

Exclusion Criteria:

* Pre-existing cognitive impairment (defined as CQI \<78 or clinical dementia).
* Severe functional dependence prior to stroke (defined as Modified Rankin Scale MRS = score 5).
* Any neurological or psychiatric comorbidity.
* Sensory disorders: visual impairment, blindness, deafness.
* Severe acquired phasic disorders: on the expressive oral side, in the presence of an inability to express oneself, which interferes with the collection of responses to neuropsychological tests; and on the receptive oral side, in the presence of an inability to understand the instructions of neuropsychological tests. Phasic functioning is systematically assessed during hospitalization by means of the NIHSS (score ≤ 2 on the "Language" sub-test), and will be rechecked clinically and psychometrically during neuropsychological assessments using the Language Screening Test (LAST) for both expression and oral comprehension. - Severe motor disorders: inability to mobilize the dominant upper limb for written neuropsychological tests.
* Contraindication to MRI.
* Pregnant women.
* HIV-positive patients: interaction of infectious pathology on cognitive functioning. Declarative, no HIV tests will be performed.
* Withdrawal of informed consent.
* Consumption of alcohol and/or narcotics on the day of neuropsychological assessments.

Where it's running

  • Nice University Hospital
    Nice, France
    Recruiting
  • cannes Hospital
    Cannes, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.